Portnow L - Search Results

1

Rates of pathologic nodal disease among cN0 and cN1 patients undergoing routine axillary ultrasound and neoadjuvant chemotherapy.

Weiss A, King C, Vincuilla J, Parker T, Portnow L, Nakhlis F, Dominici L, Mittendorf EA, King TA. Weiss A, et al. Among authors: portnow l. Breast Cancer Res Treat. 2022 Sep;195(2):181-189. doi: 10.1007/s10549-022-06677-2. Epub 2022 Jul 28. Breast Cancer Res Treat. 2022. PMID: 35900704

2

The natural history of untreated estrogen receptor-positive, Her2-negative invasive breast cancer.

Rojas KE, Manasseh DM, Rojas M, Mattocks A, Portnow L, Kantharia S, Zelenko N, Giuliano C, Borgen PI. Rojas KE, et al. Among authors: portnow l. Breast Cancer Res Treat. 2020 Jul;182(1):79-83. doi: 10.1007/s10549-020-05666-7. Epub 2020 May 12. Breast Cancer Res Treat. 2020. PMID: 32399743

3

Ultrasound visibility of select breast biopsy markers for targeted axillary node localization following neoadjuvant treatment: simulation using animal tissue models.

Portnow LH, Kwak E, Senapati GM, Kwait DC, Denison CM, Giess CS. Portnow LH, et al. Breast Cancer Res Treat. 2020 Nov;184(1):185-192. doi: 10.1007/s10549-020-05840-x. Epub 2020 Aug 8. Breast Cancer Res Treat. 2020. PMID: 32770455

4

How Often Does Retrieval of a Clipped Lymph Node Change Adjuvant Therapy Recommendations? A Prospective, Consecutive, Patient Cohort Study.

Weiss A, King C, Grossmith S, Portnow L, Raza S, Nakhlis F, Dominici L, Barbie T, Minami C, Nimbkar S, Rhei E, Mittendorf EA, King TA. Weiss A, et al. Among authors: portnow l. Ann Surg Oncol. 2022 Jun;29(6):3764-3771. doi: 10.1245/s10434-022-11324-7. Epub 2022 Jan 18. Ann Surg Oncol. 2022. PMID: 35041097

5

[No title available]

[No authors listed] [No authors listed] PMID: 35292882

6

Nodal Positivity in Early-Stage Triple-Negative Breast Cancer: Implications for Preoperative Immunotherapy.

Mittendorf EA, Kantor O, Weiss A, Richardson E, Garrido-Castro A, Portnow LH, Krop IE, Lin NU, Winer EP, Tolaney SM, King TA. Mittendorf EA, et al. Ann Surg Oncol. 2023 Jan;30(1):100-106. doi: 10.1245/s10434-022-12357-8. Epub 2022 Aug 8. Ann Surg Oncol. 2023. PMID: 35941343

7

Multidisciplinary considerations in the management of breast cancer patients receiving neoadjuvant chemotherapy.

Nakhlis F, Portnow L, Gombos E, Daylan AEC, Leone JP, Kantor O, Richardson ET, Ho A, Dunn SA, Ohri N. Nakhlis F, et al. Among authors: portnow l. Curr Probl Surg. 2022 Sep;59(9):101191. doi: 10.1016/j.cpsurg.2022.101191. Epub 2022 Jul 31. Curr Probl Surg. 2022. PMID: 36109127 No abstract available.

8

[No title available]

[No authors listed] [No authors listed] PMID: 36109128

9

Multimodality Imaging Review of HER2-positive Breast Cancer and Response to Neoadjuvant Chemotherapy.

Portnow LH, Kochkodan-Self JM, Maduram A, Barrios M, Onken AM, Hong X, Mittendorf EA, Giess CS, Chikarmane SA. Portnow LH, et al. Radiographics. 2023 Feb;43(2):e220103. doi: 10.1148/rg.220103. Radiographics. 2023. PMID: 36633970

10

Nodal positivity and systemic therapy among patients with clinical T1-T2N0 human epidermal growth factor receptor-positive breast cancer: Results from two international cohorts.

Weiss A, Martínez-Sáez O, Waks AG, Laws A, McGrath M, Tarantino P, Portnow L, Winer E, Rey M, Tapia M, Prat A, Partridge AH, Tolaney SM, Cejalvo JM, Mittendorf EA, King TA. Weiss A, et al. Among authors: portnow l. Cancer. 2023 Jun 15;129(12):1836-1845. doi: 10.1002/cncr.34750. Epub 2023 Mar 23. Cancer. 2023. PMID: 36951169

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27 results

Search Page